Methods used in preclinical assessment of anti-Buruli ulcer agents: A global perspective

Journal of Pharmacological and Toxicological Methods
Patrick Valere Fokou TsouhFabrice Fekam Boyom

Abstract

Buruli ulcer (BU) caused by Mycobacterium ulcerans is the third most common chronic mycobacterial infection in humans. Approximately 5000 cases are reported annually from at least 33 countries around the globe, especially in rural African communities. Even though anti-mycobacterial therapy is often effective for early nodular or ulcerative lesions, surgery is sometimes employed for aiding wound healing and correction of deformities. The usefulness of the antibiotherapy nonetheless is challenged by huge restrictive factors such as high cost, surgical scars and loss of income due to loss of man-hours, and in some instances employment. For these reasons, more effective and safer drugs are urgently needed, and research programs into alternative therapeutics including investigation of natural products should be encouraged. There is the need for appropriate susceptibility testing methods for the evaluation of potency. A number of biological assay methodologies are in current use, ranging from the classical agar and broth dilution assay formats, to radiorespirometric, dye-based, and fluorescent/luminescence reporter assays. Mice, rats, armadillo, guinea pigs, monkeys, grass cutters and lizards have been suggested as animal models for ...Continue Reading

References

Jul 1, 1975·The American Journal of Tropical Medicine and Hygiene·L C MarcusR H Morrow
Nov 1, 1974·Archives of Dermatology·R E KriegD H Connor
Jun 1, 1974·Infection and Immunity·J K ReadD H Connor
Nov 1, 1994·The Journal of Antibiotics·S ChandP Karuso
Oct 1, 1995·Antimicrobial Agents and Chemotherapy·G A ChungK Duncan
Jun 1, 1996·Antimicrobial Agents and Chemotherapy·T M ArainC K Stover
Aug 4, 1998·Antimicrobial Agents and Chemotherapy·F PortaelsW M Meyers
Oct 17, 1998·Journal of Clinical Microbiology·J C PalominoF Portaels
Dec 10, 1999·The American Journal of Tropical Medicine and Hygiene·D S WalshG P Walsh
Apr 6, 2001·Revue Scientifique Et Technique·F PortaelsW M Meyers
Jun 16, 2001·Antimicrobial Agents and Chemotherapy·I Orme, UNKNOWN Tuberculosis Drug Screening Program
Jul 18, 2002·Antimicrobial Agents and Chemotherapy·Juan-Carlos PalominoFrançoise Portaels
Sep 18, 2002·Antimicrobial Agents and Chemotherapy·Herve DegaJacques Grosset
May 16, 2003·Phytotherapy Research : PTR·D C NewY H Wong
Feb 6, 2004·American Journal of Physiology. Cell Physiology·A S Verkman
Mar 26, 2004·Natural Product Reports·Simon Gibbons
Oct 28, 2004·Journal of Ethnopharmacology·F TosunP Palittapongarnpim
Oct 26, 2005·Life Sciences·Guido F PauliScott G Franzblau
Jun 7, 2006·Lancet·Olivia J MillayNigel Curtis
Feb 6, 2007·Journal of Ethnopharmacology·Raju GautamSanjay M Jachak
Aug 19, 2007·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M Eddyani, F Portaels
Mar 28, 2008·PLoS Neglected Tropical Diseases·Tim Stinear, Paul D R Johnson
Feb 9, 2010·Lancet·Paul D R Johnson
Apr 28, 2010·Antimicrobial Agents and Chemotherapy·Tianyu ZhangEric L Nuermberger
Nov 17, 2010·Antimicrobial Agents and Chemotherapy·Tianyu ZhangEric L Nuermberger
Mar 15, 2011·Current Protocols in Microbiology·Robin Treuer, Shelley E Haydel

❮ Previous
Next ❯

Citations

Apr 30, 2020·Plastic and Reconstructive Surgery·Amy S XueRod J Rohrich
Jun 30, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Samuel K KwofieMichael D Wilson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Buruli Ulcer

Buruli ulcer is a progressive disease of subcutaneous tissues caused by mycobacterium ulcerans. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Related Papers

Brazilian Journal of Microbiology : [publication of the Brazilian Society for Microbiology]
Juan Gabriel Bueno Sánchez, Vladimir V Kouznetsov
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
Erica Weir
© 2021 Meta ULC. All rights reserved